[1]
“Clinical outcomes of a treat-and-extend regimen with intravitreal aflibercept injections in patients with choroidal neovascularization secondary to chronic central serous chorioretinopathy”, Ukr. j. ophthalmol. , no. 4, pp. 46–51, Aug. 2024, doi: 10.31288/oftalmolzh202444651.